Hyundai Pharmaceutical Co Ltd - Product Pipeline Review - 2016

  • ID: 4043288
  • Company Profile
  • 42 pages
  • Global Markets Direct
  • Hyundai Pharmaceutical
1 of 4
Hyundai Pharmaceutical Co Ltd - Product Pipeline Review - 2016

Summary:

‘Hyundai Pharmaceutical Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Hyundai Pharmaceutical Co Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Hyundai Pharmaceutical Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Hyundai Pharmaceutical Co Ltd
- The report provides overview of Hyundai Pharmaceutical Co Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Hyundai Pharmaceutical Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Hyundai Pharmaceutical Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Hyundai Pharmaceutical Co Ltd’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Hyundai Pharmaceutical Co Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Hyundai Pharmaceutical Co Ltd’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Introduction

Hyundai Pharmaceutical Co Ltd Snapshot

Hyundai Pharmaceutical Co Ltd Overview

Key Facts

Hyundai Pharmaceutical Co Ltd - Research and Development Overview

Key Therapeutic Areas

Hyundai Pharmaceutical Co Ltd - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Hyundai Pharmaceutical Co Ltd - Pipeline Products Glance

Hyundai Pharmaceutical Co Ltd - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Hyundai Pharmaceutical Co Ltd - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Hyundai Pharmaceutical Co Ltd - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Hyundai Pharmaceutical Co Ltd - Drug Profiles

BPS-015 SR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

choline alfoscerate SR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HD-0471042 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HD-0471953 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HD-6277 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HOB-046 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HOB-047 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HOB-051 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HOB-060 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HOB-071 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HOB-075 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HTB-005 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HTB-006 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

levodropropizine CR - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

tranexamic acid - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

UHC-1 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Hyundai Pharmaceutical Co Ltd - Pipeline Analysis

Hyundai Pharmaceutical Co Ltd - Pipeline Products by Target

Hyundai Pharmaceutical Co Ltd - Pipeline Products by Route of Administration

Hyundai Pharmaceutical Co Ltd - Pipeline Products by Molecule Type

Hyundai Pharmaceutical Co Ltd - Pipeline Products by Mechanism of Action

Hyundai Pharmaceutical Co Ltd - Dormant Projects

Hyundai Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Hyundai Pharmaceutical Co Ltd, Key Facts

Hyundai Pharmaceutical Co Ltd - Pipeline by Indication, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Stage of Development, 2016

Hyundai Pharmaceutical Co Ltd - Monotherapy Products in Pipeline, 2016

Hyundai Pharmaceutical Co Ltd - Partnered Products in Pipeline, 2016

Hyundai Pharmaceutical Co Ltd - Partnered Products/ Combination Treatment Modalities, 2016

Hyundai Pharmaceutical Co Ltd - Phase III, 2016

Hyundai Pharmaceutical Co Ltd - Phase II, 2016

Hyundai Pharmaceutical Co Ltd - Phase I, 2016

Hyundai Pharmaceutical Co Ltd - Preclinical, 2016

Hyundai Pharmaceutical Co Ltd - Discovery, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Target, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Route of Administration, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Molecule Type, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline Products by Mechanism of Action, 2016

Hyundai Pharmaceutical Co Ltd - Dormant Developmental Projects,2016

List of Figures:

Hyundai Pharmaceutical Co Ltd - Pipeline by Top 10 Indication, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Stage of Development, 2016

Hyundai Pharmaceutical Co Ltd - Monotherapy Products in Pipeline, 2016

Hyundai Pharmaceutical Co Ltd - Partnered Products in Pipeline, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Top 10 Target, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Route of Administration, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline by Molecule Type, 2016

Hyundai Pharmaceutical Co Ltd - Pipeline Products by Top 10 Mechanism of Action,
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll